Do hot flashes and night sweats from perimenopause cause abnormal uterine bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hot Flashes and Night Sweats Do Not Cause Abnormal Uterine Bleeding in Perimenopause

Hot flashes and night sweats during perimenopause do not cause abnormal uterine bleeding (AUB). While both vasomotor symptoms and AUB commonly occur during perimenopause, they represent separate manifestations of hormonal fluctuations rather than having a causal relationship 1.

Understanding Perimenopausal Symptoms

  • Perimenopause is characterized by fluctuating hormone levels as ovarian function gradually declines, leading to various symptoms including vasomotor symptoms (hot flashes and night sweats) and changes in menstrual patterns 2.

  • Hot flashes and night sweats are vasomotor symptoms defined as recurrent, transient episodes of flushing, perspiration, and sensations ranging from warmth to intense heat on the upper body and face, sometimes followed by chills 3.

  • Abnormal uterine bleeding during perimenopause has distinct causes unrelated to vasomotor symptoms 1.

Causes of Abnormal Uterine Bleeding in Perimenopause

Abnormal uterine bleeding during perimenopause can be attributed to several factors:

  • Hormonal fluctuations: Decreasing/unstable ovarian function leading to anovulatory cycles is a common cause of AUB during perimenopause 1.

  • Structural causes: According to the PALM-COEIN classification system, structural causes include:

    • Polyps (endometrial)
    • Adenomyosis
    • Leiomyomas (fibroids)
    • Malignancy or hyperplasia 3.
  • Non-structural causes: Include coagulopathies, ovulatory dysfunction, primary endometrial disorders, iatrogenic causes, and other conditions not otherwise classified 3.

  • Age-related factors: The prevalence of benign findings such as endometrial polyps and myomas increases with age, leading to more abnormal uterine bleeding during perimenopause 1.

Relationship Between Vasomotor Symptoms and AUB

  • While both hot flashes/night sweats and abnormal uterine bleeding commonly occur during perimenopause, they represent separate physiological responses to hormonal changes 2.

  • Current medical literature and guidelines do not establish a causal relationship between vasomotor symptoms and abnormal uterine bleeding 3, 1.

  • Vasomotor symptoms are primarily related to thermoregulatory dysfunction due to estrogen withdrawal, while abnormal uterine bleeding typically results from structural abnormalities or anovulatory cycles 1, 2.

Clinical Implications

  • When evaluating perimenopausal women with both vasomotor symptoms and abnormal uterine bleeding, each symptom should be assessed independently 1.

  • The presence of abnormal uterine bleeding requires appropriate investigation to rule out structural causes and malignancy, regardless of whether vasomotor symptoms are present 3.

  • Treatment approaches differ for vasomotor symptoms versus abnormal uterine bleeding, further supporting that they are distinct clinical entities 1, 2.

Important Clinical Considerations

  • Abnormal uterine bleeding in perimenopausal women should never be attributed solely to vasomotor symptoms, as this may lead to missed diagnoses of potentially serious conditions 3.

  • Transvaginal ultrasound is recommended as an ideal first step for evaluating perimenopausal abnormal uterine bleeding 1.

  • Endometrial sampling may be necessary to rule out endometrial hyperplasia or malignancy, particularly in women with risk factors 3.

  • Treatment options for abnormal uterine bleeding include hormonal treatments (oral progestogens, combined oral contraceptives, levonorgestrel intrauterine system), antifibrinolytic agents, non-steroidal anti-inflammatory drugs, and surgical interventions when indicated 1.

References

Research

Management of perimenopausal and menopausal symptoms.

BMJ (Clinical research ed.), 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.